137 related articles for article (PubMed ID: 19520214)
1. Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study.
Noble F; Bailey D; ; Tung K; Byrne JP
Clin Radiol; 2009 Jul; 64(7):699-705. PubMed ID: 19520214
[TBL] [Abstract][Full Text] [Related]
2. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
[TBL] [Abstract][Full Text] [Related]
3. N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?
Foley KG; Lewis WG; Fielding P; Karran A; Chan D; Blake P; Roberts SA
Clin Radiol; 2014 Sep; 69(9):959-64. PubMed ID: 24916652
[TBL] [Abstract][Full Text] [Related]
4. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.
Katsoulis IE; Wong WL; Mattheou AK; Damani N; Chambers J; Livingstone JI
Int J Surg; 2007 Dec; 5(6):399-403. PubMed ID: 17631431
[TBL] [Abstract][Full Text] [Related]
6. Comparison of special interest computed tomography, endosonography and histopathological stage of oesophageal cancer.
Weaver SR; Blackshaw GR; Lewis WG; Edwards P; Roberts SA; Thomas GV; Allison MC
Clin Radiol; 2004 Jun; 59(6):499-504. PubMed ID: 15145719
[TBL] [Abstract][Full Text] [Related]
7. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
[TBL] [Abstract][Full Text] [Related]
8. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.
Berrisford RG; Wong WL; Day D; Toy E; Napier M; Mitchell K; Wajed S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1112-6. PubMed ID: 18328726
[TBL] [Abstract][Full Text] [Related]
9. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer.
Keswani RN; Early DS; Edmundowicz SA; Meyers BF; Sharma A; Govindan R; Chen J; Kohlmeier C; Azar RR
Gastrointest Endosc; 2009 Jun; 69(7):1210-7. PubMed ID: 19012886
[TBL] [Abstract][Full Text] [Related]
10. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
Torrance AD; Almond LM; Fry J; Wadley MS; Lyburn ID
Surgeon; 2015 Feb; 13(1):19-33. PubMed ID: 24206935
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET nodal staging does not correlate with histopathological nodal stage for oesophageal cancers.
Devadas M; Mittal A; Lin M; Cosman P; Ziazaris W; Wilson R; Das A; Merrett N
Int J Surg; 2015 Aug; 20():113-7. PubMed ID: 26118612
[TBL] [Abstract][Full Text] [Related]
12. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
[TBL] [Abstract][Full Text] [Related]
13. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
Sandha GS; Severin D; Postema E; McEwan A; Stewart K
Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
[TBL] [Abstract][Full Text] [Related]
14. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
[TBL] [Abstract][Full Text] [Related]
15. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Westerterp M; Van Westreenen HL; Sloof GW; Plukker JT; Van Lanschot JJ
Scand J Gastroenterol Suppl; 2006; (243):116-22. PubMed ID: 16782630
[TBL] [Abstract][Full Text] [Related]
16. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma.
Kneist W; Schreckenberger M; Bartenstein P; Menzel C; Oberholzer K; Junginger T
Arch Surg; 2004 Oct; 139(10):1043-9. PubMed ID: 15492140
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer.
You JJ; Wong RK; Darling G; Gulenchyn K; Urbain JL; Evans WK
J Thorac Oncol; 2013 Dec; 8(12):1563-9. PubMed ID: 24389439
[TBL] [Abstract][Full Text] [Related]
19. [Impact of (18)F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer].
Pifarré-Montaner P; Fernández-León A; de Juan R; del Ama-Salvador ME; Galán M; Gámez-Cenzano C; Sans M
Rev Esp Med Nucl; 2009; 28(3):101-5. PubMed ID: 19558949
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
Sihvo EI; Räsänen JV; Knuuti MJ; Minn HR; Luostarinen ME; Viljanen T; Färkkilä MA; Salo JA
J Gastrointest Surg; 2004 Dec; 8(8):988-96. PubMed ID: 15585386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
